BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 13, 2004
View Archived Issues
Genentech, Phenomix Enter Immune Disorder Target Deal
Genentech Inc. signed a multiyear collaboration with Phenomix Corp. to identify and prioritize drug targets for immune disorders. (BioWorld Today)
Read More
Incyte's Reverset Phase II Positive In Treatment-Experienced Patients
Read More
Microscience Pulls IPO; Firms In UK Struggle With Valuations
Read More
Other News To Note
Read More
Appointments And Advancements
Read More